Aquisition | iBIO

Chicago-based Valinor Pharma Acquired by Grünenthal in $250 Million Deal

by John Conrad | Jul 24, 2024 | NewsBrief

Valinor Pharma, LLC (“Valinor”) has announced its acquisition by Grünenthal in an all-stock deal valued at approximately $250 million in upfront cash consideration. This acquisition marks a significant milestone for Valinor, which has owned the global...

BD Announces $4.2 Billion Acquisition of Edwards Lifesciences’ Critical Care Business

by John Conrad | Jun 3, 2024 | NewsBrief

In a major deal announced today, medical technology leader BD (Becton, Dickinson and Company) has agreed to acquire the Critical Care product group from Edwards Lifesciences for $4.2 billion in cash. The acquisition significantly expands BD’s portfolio of...